<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25775155</article-id><article-id pub-id-type="pmc">4394502</article-id><article-id pub-id-type="doi">10.3390/ijms16035741</article-id><article-id pub-id-type="publisher-id">ijms-16-05741</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The Importance of G Protein-Coupled Receptor Kinase 4 (GRK4) in Pathogenesis of Salt Sensitivity, Salt Sensitive Hypertension and Response to Antihypertensive Treatment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rayner</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="af1-ijms-16-05741">1</xref><xref rid="c1-ijms-16-05741" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Ramesar</surname><given-names>Raj</given-names></name><xref ref-type="aff" rid="af2-ijms-16-05741">2</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Van Craenenbroeck</surname><given-names>Kathleen</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-16-05741"><label>1</label>Division of Nephrology and Hypertension, University of Cape Town, Cape Town 7925, South Africa</aff><aff id="af2-ijms-16-05741"><label>2</label>MRC Human Genetics Research Unit, Division of Human Genetics, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa; E-Mail: <email>raj.ramesar@uct.ac.za</email></aff><author-notes><corresp id="c1-ijms-16-05741"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>brian.rayner@uct.ac.za</email>; Tel.: +27-21-404-3318; Fax: +27-21-406-6905.</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2015</year></pub-date><volume>16</volume><issue>3</issue><fpage>5741</fpage><lpage>5749</lpage><history><date date-type="received"><day>30</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>15</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2015</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Salt sensitivity is probably caused by either a hereditary or acquired defect of salt excretion by the kidney, and it is reasonable to consider that this is the basis for differences in hypertension between black and white people. Dopamine acts in an autocrine/paracrine fashion to promote natriuresis in the proximal tubule and thick ascending loop of Henle. G-protein receptor kinases (or GRKs) are serine and threonine kinases that phosphorylate G protein-coupled receptors in response to agonist stimulation and uncouple the dopamine receptor from its G protein. This results in a desensitisation process that protects the cell from repeated agonist exposure. <italic>GRK4</italic> activity is increased in spontaneously hypertensive rats, and infusion of <italic>GRK4</italic> antisense oligonucleotides attenuates the increase in blood pressure (BP). This functional defect is replicated in the proximal tubule by expression of <italic>GRK4</italic> variants namely p.Arg65Leu, p.Ala142Val and p.Val486Ala, in cell lines, with the p.Ala142Val showing the most activity. In humans, <italic>GRK4</italic> polymorphisms were shown to be associated with essential hypertension in Australia, BP regulation in young adults, low renin hypertension in Japan and impaired stress-induced Na excretion in normotensive black men. In South Africa, <italic>GRK4</italic> polymorphisms are more common in people of African descent, associated with impaired Na excretion in normotensive African people, and predict blood pressure response to Na restriction in African patients with mild to moderate essential hypertension. The therapeutic importance of the <italic>GRK4</italic> single nucleotide polymorphisms (SNPs) was emphasised in the African American Study of Kidney Disease (AASK) where African-Americans with hypertensive nephrosclerosis were randomised to receive amlodipine, ramipril or metoprolol. Men with the p.Ala142Val genotype were less likely to respond to metoprolol, especially if they also had the p.Arg65Leu variant. Furthermore, in the analysis of response to treatment in two major hypertension studies, the 65Leu/142Val heterozygote predicted a significantly decreased response to atenolol treatment, and the 65Leu/142Val heterozygote and 486Val homozygote were associated in an additive fashion with adverse cardiovascular outcomes, independent of BP. In conclusion, there is considerable evidence that <italic>GRK4</italic> variants are linked to impaired Na excretion, hypertension in animal models and humans, therapeutic response to dietary Na restriction and response to antihypertensive drugs. It may also underlie the difference in hypertension between different geographically derived population groups, and form a basis for pharmacogenomic approaches to treatment of hypertension.</p></abstract><kwd-group><kwd>salt sensitivity</kwd><kwd><italic>GRK4</italic></kwd><kwd>ethnicity</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>Hypertension is a complex, poorly understood disorder with strong environmental and genetic influences. Salt sensitivity is a term designated to define a group of individuals with a greater rise in blood pressure (BP) after salt loading or a greater fall in blood pressure after salt restriction [<xref rid="B1-ijms-16-05741" ref-type="bibr">1</xref>]. People of African descent (hereafter referred to as Blacks) appear to be more salt sensitive than people of Caucasian/European origins (hereafter referred to as Whites) [<xref rid="B2-ijms-16-05741" ref-type="bibr">2</xref>]. Greater sodium retention is thought to underlie the BP-determining physiology of Blacks, but specific mechanisms have not been identified. Additionally, African Americans have a higher prevalence of hypertension and morbidity from hypertension for comparable levels of BP, when compared to Whites [<xref rid="B3-ijms-16-05741" ref-type="bibr">3</xref>,<xref rid="B4-ijms-16-05741" ref-type="bibr">4</xref>].</p><p>In a recent prospective observational study in the United States, involving children and adults, plasma renin activity (PRA) and plasma aldosterone concentration were significantly lower in Blacks compared to Whites, and there was a greater rise in 24 h ambulatory BP, brain natriuretic peptide and body weight after treatment with 9-&#x003b1; fludrocortisone indicating greater sodium (Na) retention by the kidney [<xref rid="B5-ijms-16-05741" ref-type="bibr">5</xref>]. Similarly, Rayner <italic>et al</italic>. [<xref rid="B6-ijms-16-05741" ref-type="bibr">6</xref>] showed that PRA and plasma aldosterone concentrations were significantly lower in South African Blacks compared to Whites for comparable intake of Na, possibly suggesting an underlying genetic predisposition to Na retention.</p><p>Regulation of Na balance is critical for the survival of land-based animals. Every day the kidney filters approximately 25,000 mmol of Na, with 65% reabsorbed in the proximal tubule, 27% in ascending loop of Henle, 5% in the distal convoluted tubule and 3% in the collecting duct [<xref rid="B7-ijms-16-05741" ref-type="bibr">7</xref>]. As dietary intake ranges from as little as 20 mmols/day (ultra-low, hunter-gatherer diet) to as high as 300 mmols/day (in a typical Western diet), it is essential for the kidney to maintain Na homeostasis by reabsorbing over 99% of the filtered Na. Any defect in Na reabsorption (such as occurs in Barter&#x02019;s syndrome) results in Na wasting, hypotension, and massive activation of the renin-angiotensin-aldosterone system, often incompatible with long term survival [<xref rid="B8-ijms-16-05741" ref-type="bibr">8</xref>]. Barter&#x02019;s syndrome is due to a &#x0201c;loss of function&#x0201d; mutation in the Na-K-2Cl transporter located in the thick ascending loop of Henle [<xref rid="B8-ijms-16-05741" ref-type="bibr">8</xref>]. Conversely, increased function of Na transporters in the kidney, e.g., the epithelial Na channel, results in Liddle&#x02019;s syndrome characterised by hypertension, hypokalaemia, and suppressed PRA and aldosterone [<xref rid="B8-ijms-16-05741" ref-type="bibr">8</xref>].</p><p>Bochud <italic>et al.</italic> [<xref rid="B9-ijms-16-05741" ref-type="bibr">9</xref>] showed that fractional excretion of Na in the proximal convoluted tubule is highly hereditable, and fractional excretion of Na was significantly higher in Black South Africans when compared to White Belgians. Dopamine is an important regulator of Na balance in the proximal convoluted tubule, and <italic>GRK4</italic> is a serine and threonine kinase that phosphorylates G protein-coupled receptors in response to agonist stimulation. It uncouples the dopamine receptor from its G protein. In this review, the importance of GRK-4 single nucleotide polymorphisms (SNPs) in determining salt sensitivity and salt sensitive hypertension response to dietary and antihypertensive therapy in people of African descent will be explored.</p></sec><sec><title>2. Dopamine, G-Protein-Coupled Receptors and <italic>GRK4</italic></title><p>The catecholamines, dopamine and norepinephrine are synthesized from the same precursors; namely, the amino acid tyrosine and its hydroxylated product L-DOPA. (<xref ref-type="fig" rid="ijms-16-05741-f001">Figure 1</xref>) In the kidney, dopamine is mainly synthesised in the proximal tubules by decarboxylation of L-DOPA, which is transported to the tubules from the circulation as the renal tubules are unable to synthesise L-DOPA due to lack of tyrosine hydroxylase. The proximal tubules also lack dopamine &#x003b2;-hydroxylase, and there is no conversion to norepinephrine. Dopamine receptors are present on both the basolateral and apical membranes [<xref rid="B10-ijms-16-05741" ref-type="bibr">10</xref>].</p><fig id="ijms-16-05741-f001" position="float"><label>Figure 1</label><caption><p>Biosynthesis of catecholamines.</p></caption><graphic xlink:href="ijms-16-05741-g001"/></fig><p>Dopamine secreted by the tubules acts in an autocrine/paracrine fashion to regulate Na transport mainly in the renal proximal tubule and thick ascending loop of Henle [<xref rid="B10-ijms-16-05741" ref-type="bibr">10</xref>]. The dopamine receptors are distributed widely in the kidney, and the D<sub>1</sub> receptors (D<sub>1</sub>R) belong to a super family of G protein-coupled receptors, which stimulate adenyl cyclase and protein kinase A. Under conditions of Na excess, locally generated dopamine acts on D<sub>1</sub>R of the renal tubular cells to reduce Na transport and promote natriuresis. Dopamine inhibits renal Na transport by inhibiting the Na-H exchanger, and Na/phosphate co-transporter in apical membranes, and Na/HCO<sub>3</sub><sup>&#x02212;</sup> co-transporter and Na K-ATPase in basolateral membranes in the proximal tubule and thick ascending loop of Henle. Renal dopamine is responsible for over 50% of the incremental Na excretion in response to increased intake [<xref rid="B11-ijms-16-05741" ref-type="bibr">11</xref>].</p><p>Dopamine interacts with atrial natriuretic peptide (ANP), angiotensin II and &#x003b1; adrenergic receptors in the proximal tubule to maintain Na homeostasis [<xref rid="B11-ijms-16-05741" ref-type="bibr">11</xref>]. The model for bidirectional regulation of tubular Na transport is shown in <xref ref-type="fig" rid="ijms-16-05741-f002">Figure 2</xref>. There is evidence that dopamine opposes the anti-natriuretic effect of ANG II, both in the short and long term. It stimulates the activity of proximal tubular Na/K ATPase, which is abolished by dopamine or its messenger cAMP [<xref rid="B11-ijms-16-05741" ref-type="bibr">11</xref>]. In fish, dopamine is the predominant catecholamine, but in the terrestrial environment, where Na is a relatively scarce resource, norepinephrine predominates and is essential in the regulation of the anti-natriuretic forces by stimulating the Na/K ATPase in the proximal tubule. Dopamine opposes the action of norepinephrine. Atrial natriuretic peptide (ANP) is an important natriuretic hormone but it requires the presence of dopamine receptors for its full effect. The inhibitory effect of dopamine on the Na/K ATPase is potentiated by ANP.</p><fig id="ijms-16-05741-f002" position="float"><label>Figure 2</label><caption><p>Bidirectional regulation of proximal tubular Na [<xref rid="B10-ijms-16-05741" ref-type="bibr">10</xref>]. ANP = atrial natriuretic peptide receptor, D<sub>1</sub>R = dopamine receptor, &#x003b1;AR = &#x003b1; adrenergic receptor, AT1R = angiotensin 1 receptor.</p></caption><graphic xlink:href="ijms-16-05741-g002"/></fig><p>The effects of dopamine in the kidney provide a physiological model for salt-sensitive hypertension. Any defect in the dopaminergic system will result in unopposed action of ANG II and norepinephrine, and impaired action of ANP on the proximal tubule, resulting in a pronounced antinatriuretic effect [<xref rid="B11-ijms-16-05741" ref-type="bibr">11</xref>].</p><p>Current research suggests that a defect in the D<sub>1</sub>R is not a likely candidate for salt-sensitive hypertension in humans. However, the uncoupling of the D<sub>1</sub>R from its G protein effector complex is similar to a desensitisation process [<xref rid="B12-ijms-16-05741" ref-type="bibr">12</xref>]. This is a mechanism which protects the cell from repeated agonist exposure. Desensitisation involves several processes including phosphorylation, sequestration and degradation of receptor protein. The initial step in this process (phosphorylation) is mediated by a member of the G protein-coupled receptor kinase (GRK). GRKs are serine and threonine kinases that phosphorylate G protein-coupled receptors in response to agonist stimulation [<xref rid="B12-ijms-16-05741" ref-type="bibr">12</xref>]. The phosphorylation of G protein-coupled receptor kinases, including D<sub>1</sub>R, leads to binding with members of the arrestin family of proteins that uncouple the receptor from its G protein, and reduction in the functional response [<xref rid="B12-ijms-16-05741" ref-type="bibr">12</xref>].</p></sec><sec><title>3. The Role of <italic>GRK4</italic> in the Pathogenesis of Salt Sensitivity in Animal Models</title><p>In hypertension, there appears to be constitutive desensitisation of the renal D<sub>1</sub>R [<xref rid="B11-ijms-16-05741" ref-type="bibr">11</xref>]. This appears to be caused by GRK as decreasing its activity or expression in the proximal tubular cells in hypertensives normalises the ability of D<sub>1</sub>R to increase cAMP. In the proximal tubule, <italic>GRK4</italic> is the most important component, compared to other GRKs. <italic>GRK4</italic> activity is increased in spontaneously hypertensive rats, and infusion of <italic>GRK4</italic> antisense oligonucleotides attenuates the increase in BP [<xref rid="B13-ijms-16-05741" ref-type="bibr">13</xref>]. This functional defect is replicated in the proximal tubule by expression of <italic>GRK4</italic> variants in cell lines, and this is rectified by prevention of <italic>GRK4</italic> expression [<xref rid="B14-ijms-16-05741" ref-type="bibr">14</xref>]. These three tested variants were the p.Arg65Leu, p.Ala142Val, and p.Val486Ala, with the p.Ala142Val showing the most activity [<xref rid="B14-ijms-16-05741" ref-type="bibr">14</xref>]. This impairment of dopaminergic function, as evidenced by the <italic>GRK4</italic> variants in animal models, would allow the antinatriuretic function of ANG II and norepinephrine to be unopposed, which may then be responsible for salt sensitivity and rise in BP. It is therefore an attractive candidate gene for human salt sensitivity and hypertension.</p><p>In addition, <italic>GRK4</italic> polymorphisms may affect BP through enhanced activity of AT1 receptors. <italic>GRK4</italic> is expressed in vascular smooth muscle cells of the aorta and heterologous expression of the <italic>GRK4&#x003b3;</italic> variant p.Ala142Val in A10 cells increased AT1 receptor protein expression and increase in intracellular calcium concentration [<xref rid="B15-ijms-16-05741" ref-type="bibr">15</xref>]. Angiotensin II-mediated vasoconstriction of the aorta was also higher in <italic>GRK4&#x003b3;</italic> p.Ala142Val than in wild-type transgenic mice.</p></sec><sec><title>4. The Role of <italic>GRK4</italic> Variants on Na Excretion in Humans</title><p>Several lines of evidence point to a role for <italic>GRK4</italic> variants in the pathogenesis of salt sensitivity and salt sensitive hypertension in humans, especially in African populations. The p.Arg65Leu allele was also associated with impaired stress-induced Na excretion in normotensive Black men [<xref rid="B16-ijms-16-05741" ref-type="bibr">16</xref>]. In a study from South Africa, salt excretion was examined in healthy normotensive and lean black and white men after an acute saline load [<xref rid="B17-ijms-16-05741" ref-type="bibr">17</xref>]. The <italic>GRK4</italic> p.Ala142Val polymorphism, which was significantly more frequent in black men, was associated with significantly lower plasma aldosterone concentrations and impaired incremental urinary Na excretion. Hypertension-related polymorphisms and cardiovascular indices were also analyzed in 97 normotensive, healthy Japanese adults. NT-proBNP levels were significantly higher in subjects with two or more <italic>GRK4</italic> polymorphic alleles strongly suggesting enhanced Na retention [<xref rid="B18-ijms-16-05741" ref-type="bibr">18</xref>]. Sodium excretion was inversely related to the number of <italic>GRK4</italic> variants in hypertensive persons, and the natriuretic response to dopaminergic stimulation was impaired in normotensive persons having <italic>GRK4</italic> gene variants [<xref rid="B19-ijms-16-05741" ref-type="bibr">19</xref>].</p></sec><sec><title>5. <italic>GRK4</italic> Variants and Hypertension</title><p>In an Australian study, involving 168 unrelated white subjects/patients and 312 normotensive controls, <italic>GRK4</italic> polymorphisms were associated with essential hypertension [<xref rid="B20-ijms-16-05741" ref-type="bibr">20</xref>]. Furthermore, a recent study linked the <italic>GRK4</italic> variants, in particular p.Arg65Leu, with BP regulation in adolescents and young adults [<xref rid="B21-ijms-16-05741" ref-type="bibr">21</xref>]. A Japanese study of hypertensive subjects developed a multi-variant genetic model based on the p.Arg65Leu, p.Ala142Val, and p.Val486Ala changes in <italic>GRK4</italic> which was 94.4% predictive of salt-sensitive hypertension, while a single-variant model with a single p.Ala142Val variant (in <italic>GRK4</italic>) was only 78.4% predictive [<xref rid="B19-ijms-16-05741" ref-type="bibr">19</xref>].</p><p>The putative pathogenesis of salt sensitive hypertension due to <italic>GRK4</italic> SNPs is shown in <xref ref-type="fig" rid="ijms-16-05741-f003">Figure 3</xref> demonstrating the interaction of genes and environment. Environmental factors interplay with the underlying genetic factors to develop the &#x0201c;perfect storm&#x0201d; for the development of hypertension.</p><fig id="ijms-16-05741-f003" position="float"><label>Figure 3</label><caption><p>Putative pathogenesis of salt sensitive hypertension related to GRK-4 SNPs. SNS = sympathetic nervous system, RAAS = renin-angiotensin-aldosterone system.</p></caption><graphic xlink:href="ijms-16-05741-g003"/></fig></sec><sec><title>6. <italic>GRK4</italic> Variants and Response to Dietary and Pharmacological Intervention</title><p>In South Africa, <italic>GRK4</italic> polymorphisms are more common in people of African descent, are associated with impaired Na excretion in normotensive people, and predict blood pressure response to Na restriction in African patients with mild to moderate essential hypertension [<xref rid="B22-ijms-16-05741" ref-type="bibr">22</xref>]. The therapeutic importance of the <italic>GRK4</italic> SNPs was emphasised in the African American Study of Kidney Disease (AASK) where African-Americans with hypertensive nephrosclerosis were randomised to receive amlodipine, ramipril or metoprolol [<xref rid="B23-ijms-16-05741" ref-type="bibr">23</xref>]. Men with the p.142Ala genotype were less likely to respond to metoprolol, especially if they had co-inherited the p.65Leu variant. Furthermore, in the analysis of response to treatment in two major hypertension studies, the 65Leu/142Val haplotype predicted a significantly decreased response to atenolol treatment, and the 65Leu/142Val heterozygote and the 486Val/486Val homozygote were associated in an additive fashion with adverse CV outcomes independent of BP [<xref rid="B24-ijms-16-05741" ref-type="bibr">24</xref>]. The effects of GRK-4 variants are summarized in <xref ref-type="table" rid="ijms-16-05741-t001">Table 1</xref>.</p><table-wrap id="ijms-16-05741-t001" position="float"><object-id pub-id-type="pii">ijms-16-05741-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of the associations of GRK variants with Na excretion and hypertension.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" style="border-top:solid thin;border-bottom:solid thin" align="center" rowspan="1" colspan="1">GRK Variant</th><th valign="middle" style="border-top:solid thin;border-bottom:solid thin" align="center" rowspan="1" colspan="1">Parameter</th><th valign="middle" style="border-top:solid thin;border-bottom:solid thin" align="center" rowspan="1" colspan="1">Comment</th></tr></thead><tbody><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Arg65Leu, p.Ala142Val, and p.Val486Ala</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">Hypertension in rats</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Ala142Val shows greatest activity</td></tr><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Ala142Val</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">Enhanced activity of AT1 in smooth muscle</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Arg65Leu</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">Impaired stress related Na excretion in normotensive blacks</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Ala142Val</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">Impaired incremental Na excretion in healthy men, and lower aldosterone levels</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Ala142Val significantly more common in Blacks compared to Whites</td></tr><tr><td valign="middle" align="center" rowspan="1" colspan="1">p.Arg65Leu, p.Ala142Val, and p.Val486Ala</td><td valign="middle" align="center" rowspan="1" colspan="1">Impaired Na excretion and higher BNP levels in healthy Japanese with two or more variants</td><td valign="middle" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" style="border-top:solid thin;border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Val486Ala</td><td valign="middle" style="border-top:solid thin;border-bottom:solid thin" align="center" rowspan="1" colspan="1">Association with hypertension in Australian population</td><td valign="middle" style="border-top:solid thin;border-bottom:solid thin" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Arg65Leu, p.Ala142Val, and p.Val486Ala</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">94.4% predictive of salt sensitive renin hypertension in Japanese population</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Ala142Val 78.4% predictive</td></tr><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.Arg65Leu, p.Ala142Val</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">BP response to Na restriction in black South Africans with hypertension </td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">p.142Ala genotype</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">In AASK males less likely to respond to metoprolol</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">Especially if co-inherited the p.65Leu variant</td></tr><tr><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">65Leu/142Val haplotype</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">In two major hypertension studies predicted a reduced response to atenolol and increased cardiovascular outcomes</td><td valign="middle" style="border-bottom:solid thin" align="center" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></table-wrap></sec><sec><title>7. Conclusions</title><p>There is now mounting evidence that <italic>GRK4</italic> variants are linked to impaired Na excretion, hypertension in animal models and humans, therapeutic response to dietary Na restriction and response to antihypertensive drugs. It may also underlie the difference in hypertension between individuals of African and European origin, and form a basis to a pharmacogenomics approach to the understanding and treatment of hypertension.</p></sec></body><back><notes><title>Author Contributions</title><p>Brian Rayner, Raj Ramesar contributed to the research, writing and reviewing of the manuscript.</p></notes><notes><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-16-05741"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>M.H.</given-names></name></person-group>
<article-title>Salt sensitivity of blood pressure in humans</article-title>
<source>Hypertension</source>
<year>1996</year>
<volume>27</volume>
<fpage>481</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="doi">10.1161/01.HYP.27.3.481</pub-id>
<pub-id pub-id-type="pmid">8613190</pub-id></element-citation></ref><ref id="B2-ijms-16-05741"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luft</surname><given-names>F.C.</given-names></name><name><surname>Grim</surname><given-names>C.E.</given-names></name><name><surname>Higgins</surname><given-names>J.T.</given-names><suffix>Jr.</suffix></name><name><surname>Weinberger</surname><given-names>M.H.</given-names></name></person-group>
<article-title>Differences in response to sodium administration in normotensive white and black subjects</article-title>
<source>J. Lab. Clin. Med.</source>
<year>1977</year>
<volume>90</volume>
<fpage>555</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="pmid">894106</pub-id></element-citation></ref><ref id="B3-ijms-16-05741"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mensah</surname><given-names>G.A.</given-names></name><name><surname>Mokdad</surname><given-names>A.H.</given-names></name><name><surname>Ford</surname><given-names>E.S.</given-names></name><name><surname>Greenlund</surname><given-names>K.J.</given-names></name><name><surname>Croft</surname><given-names>J.B.</given-names></name></person-group>
<article-title>State of disparities in cardiovascular health in the United States</article-title>
<source>Circulation</source>
<year>2005</year>
<volume>1111</volume>
<fpage>1233</fpage>
<lpage>1241</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.0000158136.76824.04</pub-id>
<pub-id pub-id-type="pmid">15769763</pub-id></element-citation></ref><ref id="B4-ijms-16-05741"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Redmond</surname><given-names>N.</given-names></name><name><surname>Baer</surname><given-names>H.J.</given-names></name><name><surname>Hicks</surname><given-names>L.S.</given-names></name></person-group>
<article-title>Health behaviors and racial disparity in blood pressure control in the National Health and Nutrition Examination Survey</article-title>
<source>Hypertension</source>
<year>2011</year>
<volume>57</volume>
<fpage>383</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.110.161950</pub-id>
<pub-id pub-id-type="pmid">21300667</pub-id></element-citation></ref><ref id="B5-ijms-16-05741"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tu</surname><given-names>W.</given-names></name><name><surname>Eckert</surname><given-names>G.J.</given-names></name><name><surname>Hannon</surname><given-names>T.S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Pratt</surname><given-names>L.M.</given-names></name><name><surname>Wagner</surname><given-names>M.A.</given-names></name><name><surname>DiMeglio</surname><given-names>L.A.</given-names></name><name><surname>Jung</surname><given-names>J.</given-names></name><name><surname>Pratt</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Racial differences in sensitivity of blood pressure to aldosterone</article-title>
<source>Hypertension</source>
<year>2014</year>
<volume>63</volume>
<fpage>1212</fpage>
<lpage>1218</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.02989</pub-id>
<pub-id pub-id-type="pmid">24711519</pub-id></element-citation></ref><ref id="B6-ijms-16-05741"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rayner</surname><given-names>B.L.</given-names></name><name><surname>Meyers</surname><given-names>J.E.</given-names></name><name><surname>Opie</surname><given-names>L.H.</given-names></name><name><surname>Trinder</surname><given-names>Y.A.</given-names></name><name><surname>Davidson</surname><given-names>J.S.</given-names></name></person-group>
<article-title>Screening for primary aldosteronism&#x02014;Normal ranges for aldosterone and renin in three South African groups</article-title>
<source>S. Afr. Med. J.</source>
<year>2001</year>
<volume>91</volume>
<fpage>594</fpage>
<lpage>599</lpage>
<pub-id pub-id-type="pmid">11544978</pub-id></element-citation></ref><ref id="B7-ijms-16-05741"><label>7.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bailey</surname><given-names>M.A.</given-names></name><name><surname>Shirley</surname><given-names>D.G.</given-names></name><name><surname>Unwin</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Renal physiology</article-title>
<source>Comprehensive Clinical Nephrology</source>
<edition>5th ed.</edition>
<person-group person-group-type="editor"><name><surname>Johnson</surname><given-names>R.J.</given-names></name><name><surname>Feehally</surname><given-names>J.</given-names></name><name><surname>Floege</surname><given-names>J.</given-names></name></person-group>
<publisher-name>Elsevier, Sanders</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2014</year>
<volume>Chapter 2</volume>
<fpage>14</fpage>
<lpage>27</lpage>
</element-citation></ref><ref id="B8-ijms-16-05741"><label>8.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gross</surname><given-names>P.</given-names></name><name><surname>Heduschka</surname><given-names>P.</given-names></name></person-group>
<article-title>Inherited disorders of sodium and water metabolism</article-title>
<source>Comprehensive Clinical Nephrology</source>
<edition>5th ed.</edition>
<person-group person-group-type="editor"><name><surname>Johnson</surname><given-names>R.J.</given-names></name><name><surname>Feehally</surname><given-names>J.</given-names></name><name><surname>Floege</surname><given-names>J.</given-names></name></person-group>
<publisher-name>Elsevier, Sanders</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2014</year>
<volume>Chapter 49</volume>
<fpage>579</fpage>
<lpage>589</lpage>
</element-citation></ref><ref id="B9-ijms-16-05741"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bochud</surname><given-names>M.</given-names></name><name><surname>Staessen</surname><given-names>J.A.</given-names></name><name><surname>Maillard</surname><given-names>M.</given-names></name><name><surname>Mazeko</surname><given-names>M.J.</given-names></name><name><surname>Kuznetsova</surname><given-names>T.</given-names></name><name><surname>Woodiwiss</surname><given-names>A.</given-names></name><name><surname>Richart</surname><given-names>T.</given-names></name><name><surname>Norton</surname><given-names>G.</given-names></name><name><surname>Thijs</surname><given-names>L.</given-names></name><name><surname>Elston</surname><given-names>R.</given-names></name><etal/></person-group>
<article-title>Ethnic differences in proximal and distal tubular sodium reabsorbtion are heritable in black and white populations</article-title>
<source>J. Hypertens.</source>
<year>2009</year>
<volume>27</volume>
<fpage>606</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="pmid">19262228</pub-id></element-citation></ref><ref id="B10-ijms-16-05741"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aperia</surname><given-names>A.C.</given-names></name></person-group>
<article-title>Intrarenal dopamine: A key signal in the interactive regulation of sodium metabolism</article-title>
<source>Annu. Rev. Physiol.</source>
<year>2000</year>
<volume>62</volume>
<fpage>621</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.physiol.62.1.621</pub-id>
<pub-id pub-id-type="pmid">10845105</pub-id></element-citation></ref><ref id="B11-ijms-16-05741"><label>11.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jose</surname><given-names>P.A.</given-names></name><name><surname>Eisner</surname><given-names>G.M.</given-names></name><name><surname>Felder</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Dopamine and the kidney: A role in hypertension?</article-title>
<source>Curr. Opin. Nephrol. Hypertens.</source>
<year>2003</year>
<volume>12</volume>
<fpage>189</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1097/00041552-200303000-00010</pub-id>
<pub-id pub-id-type="pmid">12589180</pub-id></element-citation></ref><ref id="B12-ijms-16-05741"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jose</surname><given-names>P.A.</given-names></name><name><surname>Eisner</surname><given-names>G.M.</given-names></name><name><surname>Felder</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Role of dopamine receptors in the kidney in the regulation of blood pressure</article-title>
<source>Curr. Opin. Nephrol. Hypertens.</source>
<year>2002</year>
<volume>11</volume>
<fpage>87</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1097/00041552-200201000-00013</pub-id>
<pub-id pub-id-type="pmid">11753092</pub-id></element-citation></ref><ref id="B13-ijms-16-05741"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanada</surname><given-names>H.</given-names></name><name><surname>Yatabe</surname><given-names>J.</given-names></name><name><surname>Midorikawa</surname><given-names>S.</given-names></name><name><surname>Katoh</surname><given-names>T.</given-names></name><name><surname>Hashimoto</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zeng</surname><given-names>C.</given-names></name><etal/></person-group>
<article-title>Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression</article-title>
<source>Hypertension</source>
<year>2006</year>
<volume>47</volume>
<fpage>1131</fpage>
<lpage>1139</lpage>
<pub-id pub-id-type="pmid">16636192</pub-id></element-citation></ref><ref id="B14-ijms-16-05741"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Felder</surname><given-names>R.</given-names></name><name><surname>Sanada</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Watanabe</surname><given-names>H.</given-names></name><name><surname>Asico</surname><given-names>L.D.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>I.</given-names></name><name><surname>Williams</surname><given-names>S.M.</given-names></name><etal/></person-group>
<article-title>G protein-coupled receptor kinase 4 variants in human essential hypertension</article-title>
<source>Proc. Natl. Acad. Sci. USA</source>
<year>2002</year>
<volume>99</volume>
<fpage>3872</fpage>
<lpage>3877</lpage>
<pub-id pub-id-type="pmid">11904438</pub-id></element-citation></ref><ref id="B15-ijms-16-05741"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Fu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><etal/></person-group>
<article-title>Role of <italic>GRK4</italic> in the Regulation of Arterial AT1 Receptor in Hypertension</article-title>
<source>Hypertension</source>
<year>2014</year>
<volume>63</volume>
<fpage>289</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">24218433</pub-id></element-citation></ref><ref id="B16-ijms-16-05741"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Snieder</surname><given-names>H.</given-names></name><name><surname>Treiber</surname><given-names>F.A.</given-names></name><name><surname>Harshfield</surname><given-names>G.A.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name></person-group>
<article-title>The G protein-coupled receptor kinase 4 gene modulates stress-induced sodium excretion in black normotensive adolescents</article-title>
<source>Pediatr. Res.</source>
<year>2006</year>
<volume>60</volume>
<fpage>440</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.1203/01.pdr.0000238250.64591.44</pub-id>
<pub-id pub-id-type="pmid">16940246</pub-id></element-citation></ref><ref id="B17-ijms-16-05741"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rayner</surname><given-names>B.</given-names></name><name><surname>Musekiwa</surname><given-names>A.</given-names></name><name><surname>Lombard</surname><given-names>C.</given-names></name><name><surname>Ramesar</surname><given-names>R.</given-names></name></person-group>
<article-title>The A142V polymorphism of the G protein-coupled receptor kinase 4 gene predicts natriuretic response to saline challenge in young normotensive lean Black and White South African men</article-title>
<source>Nephrol. Rev.</source>
<year>2011</year>
<volume>3</volume>
<fpage>e9</fpage>
<pub-id pub-id-type="doi">10.4081/nr.2011.e9</pub-id>
</element-citation></ref><ref id="B18-ijms-16-05741"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yatabe</surname><given-names>Y.</given-names></name><name><surname>Yatabe</surname><given-names>M.S.</given-names></name><name><surname>Yoneda</surname><given-names>M.</given-names></name><name><surname>Felder</surname><given-names>R.A.</given-names></name><name><surname>Jose</surname><given-names>P.A.</given-names></name><name><surname>Sanada</surname><given-names>H.</given-names></name></person-group>
<article-title>Hypertension-related gene polymorphisms of G-protein-coupled receptor kinase 4 are associated with NT-proBNP concentration in normotensive healthy adults</article-title>
<source>Int. J. Hypertens.</source>
<year>2012</year>
<volume>2012</volume>
<pub-id pub-id-type="doi">10.1155/2012/806810</pub-id>
</element-citation></ref><ref id="B19-ijms-16-05741"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanada</surname><given-names>H.</given-names></name><name><surname>Yatabe</surname><given-names>J.</given-names></name><name><surname>Midorikawa</surname><given-names>S.</given-names></name><name><surname>Hashimoto</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name><name><surname>Moore</surname><given-names>J.H.</given-names></name><name><surname>Ritchie</surname><given-names>M.D.</given-names></name><name><surname>Williams</surname><given-names>S.M.</given-names></name><name><surname>Pezzullo</surname><given-names>J.C.</given-names></name><name><surname>Sasaki</surname><given-names>M.</given-names></name><etal/></person-group>
<article-title>Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension</article-title>
<source>Clin. Chem.</source>
<year>2006</year>
<volume>52</volume>
<fpage>352</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="pmid">16439609</pub-id></element-citation></ref><ref id="B20-ijms-16-05741"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Speirs</surname><given-names>H.J.L.</given-names></name><name><surname>Katyk</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>N.N.</given-names></name><name><surname>Benjafield</surname><given-names>A.V.</given-names></name><name><surname>Wang</surname><given-names>W.Y.S.</given-names></name><name><surname>Morris</surname><given-names>B.J.</given-names></name></person-group>
<article-title>Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension</article-title>
<source>J. Hypertens.</source>
<year>2004</year>
<volume>22</volume>
<fpage>931</fpage>
<lpage>936</lpage>
<pub-id pub-id-type="doi">10.1097/00004872-200405000-00014</pub-id>
<pub-id pub-id-type="pmid">15097232</pub-id></element-citation></ref><ref id="B21-ijms-16-05741"><label>21.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Treiber</surname><given-names>F.A.</given-names></name><name><surname>Harshfield</surname><given-names>G.A.</given-names></name><name><surname>Snieder</surname><given-names>H.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name></person-group>
<article-title>The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins</article-title>
<source>Am. J. Hypertens.</source>
<year>2006</year>
<volume>19</volume>
<fpage>61</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjhyper.2005.07.007</pub-id>
<pub-id pub-id-type="pmid">16461192</pub-id></element-citation></ref><ref id="B22-ijms-16-05741"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rayner</surname><given-names>B.</given-names></name><name><surname>Ramesar</surname><given-names>R.</given-names></name><name><surname>Steyn</surname><given-names>K.</given-names></name><name><surname>Levitt</surname><given-names>N.</given-names></name><name><surname>Lombard</surname><given-names>C.</given-names></name><name><surname>Charlton</surname><given-names>K.</given-names></name></person-group>
<article-title>G-protein-coupled receptor kinase 4 (GRK-4) polymorphisms predict blood pressure response to dietary modification in black patients with mild to moderate hypertension</article-title>
<source>J. Hum. Hypertens.</source>
<year>2011</year>
<volume>26</volume>
<fpage>334</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1038/jhh.2011.33</pub-id>
<pub-id pub-id-type="pmid">21544086</pub-id></element-citation></ref><ref id="B23-ijms-16-05741"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhatnagar</surname><given-names>V.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>D.T.</given-names></name><name><surname>Brophy</surname><given-names>V.H.</given-names></name><name><surname>Schork</surname><given-names>N.J.</given-names></name><name><surname>Richard</surname><given-names>E.</given-names></name><name><surname>Salem</surname><given-names>R.M.</given-names></name><name><surname>Nievergelt</surname><given-names>C.M.</given-names></name><name><surname>Bakris</surname><given-names>G.L.</given-names></name><name><surname>Middleton</surname><given-names>J.P.</given-names></name><name><surname>Norris</surname><given-names>K.C.</given-names></name><etal/></person-group>
<article-title>G-Protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among african americans: Sex-specificity and interactions</article-title>
<source>Am. J. Hypertens.</source>
<year>2009</year>
<volume>22</volume>
<fpage>332</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="pmid">19119263</pub-id></element-citation></ref><ref id="B24-ijms-16-05741"><label>24.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vandell</surname><given-names>A.G.</given-names></name><name><surname>Lobmeyer</surname><given-names>M.T.</given-names></name><name><surname>Gawronski</surname><given-names>B.E.</given-names></name><name><surname>Langaee</surname><given-names>T.Y.</given-names></name><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Gums</surname><given-names>J.G.</given-names></name><name><surname>Beitelshees</surname><given-names>A.L.</given-names></name><name><surname>Turner</surname><given-names>S.T.</given-names></name><name><surname>Chapman</surname><given-names>A.B.</given-names></name><name><surname>Cooper-Dehoff</surname><given-names>R.M.</given-names></name><etal/></person-group>
<article-title>G protein receptor kinase 4 polymorphisms: &#x003b2;-Blocker Pharmacogenetics and treatment-related outcomes in Hypertension</article-title>
<source>Hypertension</source>
<year>2012</year>
<volume>60</volume>
<fpage>957</fpage>
<lpage>964</lpage>
<pub-id pub-id-type="pmid">22949529</pub-id></element-citation></ref></ref-list></back></article>